Kura Oncology Announces up to $300 Million Strategic Financing Agreement
November 10, 2026
November 10, 2026
PALO ALTO, California, Nov. 10 [Category: BizLaw/Legal] -- Cooley, a law firm, posted the following news release:
* * *
Kura Oncology Announces up to $300 Million Strategic Financing Agreement
*
Cooley advised Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for cancer, on its up to $300 million strategic debt, equity and royalty financing agreements with affiliates of Oberland Capital. The financin . . .
* * *
Kura Oncology Announces up to $300 Million Strategic Financing Agreement
*
Cooley advised Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for cancer, on its up to $300 million strategic debt, equity and royalty financing agreements with affiliates of Oberland Capital. The financin . . .
